Skip to content

Study of the Impact of Welding Fumes on the Arterial System : RISCAS Study

Study of the Impact of Welding Fumes on the Arterial System : RISCAS Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03281239
Acronym
RISCAS
Enrollment
51
Registered
2017-09-13
Start date
2017-11-28
Completion date
2019-06-24
Last updated
2022-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effects of Welding Fumes Components

Keywords

welder, airport agent, Welding fumes

Brief summary

Metals and oxydes are found in welding fumes and are thought to participate in increasing cardiovascular risk in exposed workers. Investigators aimed to evaluate the impact of this occupational exposure on cardiovascular system in a highly exposed population, ship repairing welders and to compare this population to paired controls.

Detailed description

In an exposed-non-exposed study, investigators will include 30 welders and 30 airport runway agents for control. As part of cardiovascular independent risk factors, microvascular endothelial function will be evaluated directly by laser Doppler flowmetry. Blood samples will be also collected and circulating markers of endothelial function (VW factor, E-selectin, VCAM, ICAM, circulating DNA), inflammation (CRP, IL-1β, IL-8, TNFα, IL-10), platelet activation (procoagulant microparticles, thrombin generation, fibin monomer) will be measured. A complete clinical and functional cardiovascular status will be documented in every participant.

Interventions

DIAGNOSTIC_TESTLaser doppler, blood tests, and holter ECG

Diagnostic tests : * laser doppler * blood tests * Holter ECG. No drug and no placebo were used in this arm.

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male or Female ≥ 18 years * Employee performing welding or airport operations * free, informed and written consent * Being affiliated to a social security system

Exclusion criteria

* Taking cardiovascular medications which modify endothelial function and / or coagulation (antiplatelet, antihypertensive, cardiotropic). * People with a history of ischemic cardiovascular disease, thrombotic disease, chronic inflammatory disease * Pregnant women * People with health status would be likely, in the baseline state, to have parameters studied in the study disrupted.

Design outcomes

Primary

MeasureTime frameDescription
Vascular reactivity1 dayAssessement of microvascular reactivity by laser Doppler flowmetry associated to iontophoretic administration of ACh and SNP

Secondary

MeasureTime frameDescription
Coagulation activation1 dayAssessment of markers of blood coagulation
vascular inflammation1 dayAssessment of factors of inflammation
Impregnation of metals activation1 dayAssessment of impregnation factor
Oxidative stress activation1 dayAssessment of markers of oxidative stress

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026